Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for ...

Each stock option has a 10-year term and is subject to the terms and conditions of Akebia's inducement award program and a ...

Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company’s ...

Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company's lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development ...

Definitive Healthcare (DH) announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation ...

The Texas Legislature and Mayor John Whitmire may undo reforms to Houston’s police and firefighter pensions, worrying experts ...

On May 22, 2025, the Supreme Court of the United States affirmed prosecutors’ ability to pursue mail and wire fraud charges under the ...

Ghana Institute of Management and Public Administration (GIMPA) in collaboration with the Konrad Adenauer Stiftung (KAS) post ...

The options were granted as an inducement material to each employee entering into employment with Akebia. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced the grant of inducement equity awards to the company’s newly appointed EVP, Chief Commercial Officer, Global Head of Software Sales & Marketing ...

The Supreme Court resolved a circuit split on the scope of the federal wire fraud statute, 18 U.S.C. § 1343, in Kousisis v.